| Genome-scale screens identify factors regulating tumor cell responses to natural killer cells M Sheffer, E Lowry, N Beelen, M Borah, SNA Amara, CC Mader, JA Roth, ... Nature Genetics 53 (8), 1196-1206, 2021 | 61 | 2021 |
| Rapid signaling reactivation after targeted BRAF inhibition predicts the proliferation of individual melanoma cells from an isogenic population P Khoshkenar, E Lowry, A Mitchell Scientific Reports 11 (1), 15473, 2021 | 2 | 2021 |
| Molecular markers of MM cell sensitivity and resistance to natural killer cells: implications for anti-MM immunotherapy S Gandolfi, M Sheffer, E Lowry, O Dashevsky, R Shirasaki, ... Clinical Lymphoma, Myeloma and Leukemia 19 (10), e168-e169, 2019 | 1 | 2019 |
| Drug Development M Sheffer, E Lowry, N Beelen, M Borah, SNA Amara, CC Mader Cell, 2021 | | 2021 |
| Abstract PO041: Landscape of molecular events regulating tumor cell responses to natural killer cells M Sheffer, E Lowry, N Beelen, M Borah, SNA Amara, CC Mader, J Roth, ... Cancer Immunology Research 9 (2_Supplement), PO041-PO041, 2021 | | 2021 |
| Heterogeneity of Molecular Mechanisms Determining Blood Cancer Cell Lines Resistance to Natural Killer Cells in the Context of Tumor-Stromal Interactions: Insights from Studies … S Gandolfi, M Sheffer, O Dufva, K Saeed, E Lowry, O Dashevsky, ... Blood 134, 620, 2019 | | 2019 |
| Identification of Molecular Markers of Tumor Cell Sensitivity and Resistance to Natural Killer Cells through Genome-Wide CRISPR Activation and CRISPR Editing Screens in … S Gandolfi, M Sheffer, E Lowry, O Dashevsky, R Shirasaki, RDM Simoes, ... Blood 132, 1115, 2018 | | 2018 |
| Identification and Validation of Molecular Markers of Tumor Cell Resistance to Natural Killer Cells through CRISPR-Based Screens and Large-Scale Phenotypic Screens of Pooled … M Sheffer, L Wieten, C Yu, Y Yu, O Dashevsky, E Lowry, J Roth, ... Blood 130, 623, 2017 | | 2017 |
